E Fund Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.02M Sell
19,278
-2,515
-12% -$128K 0.05% 168
2025
Q1
$943K Buy
21,793
+6,687
+44% +$339K 0.05% 176
2024
Q4
$849K Sell
15,106
-1,470
-9% -$91.5K 0.04% 167
2024
Q3
$1.13M Sell
16,576
-10,303
-38% -$581K 0.06% 134
2024
Q2
$1.14M Buy
26,879
+19,661
+272% +$1.08M 0.06% 116
2024
Q1
$498K Sell
7,218
-203
-3% -$12.8K 0.03% 158
2023
Q4
$549K Buy
7,421
+1,583
+27% +$104K 0.03% 139
2023
Q3
$398K Buy
5,838
+751
+15% +$63.7K 0.03% 169
2023
Q2
$478K Sell
5,087
-1,143
-18% -$89.2K 0.04% 120
2023
Q1
$422K Sell
6,230
-3,251
-34% -$209K 0.03% 149
2022
Q4
$469K Sell
9,481
-2,237
-19% -$91.4K 0.04% 139
2022
Q3
$381K Buy
11,718
+1,098
+10% +$45.3K 0.04% 192
2022
Q2
$418K Buy
10,620
+6,345
+148% +$339K 0.04% 180
2022
Q1
$299K Buy
+4,275
New +$312K 0.01% 195

Other funds holding EXAS

E Fund Management's EXAS Position: Q2 2025 in Review

E Fund Management reduced its Exact Sciences (EXAS) stake by 12% in Q2 2025, selling an estimated $128K and leaving 19,278 shares worth $1.02M. The position accounts for 0.05% of the portfolio, ranked #168.

E Fund Management first reported a position in EXAS in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.14M in Q2 2024. 557 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • E Fund Management held 19,278 shares of Exact Sciences worth $1.02M as of Q2 2025.
  • E Fund Management sold 2,515 Exact Sciences shares in Q2 2025, an estimated $128K.
  • Exact Sciences made up 0.05% of E Fund Management's portfolio in Q2 2025, its #168 holding.
  • E Fund Management first reported a position in Exact Sciences in Q1 2022 and has held it in 14 quarters since.
  • E Fund Management's Exact Sciences position peaked at $1.14M in Q2 2024.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.